Document And Entity Information - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2019 |
Mar. 17, 2020 |
Jun. 28, 2019 |
|
| Document And Entity Information [Abstract] | |||
| Document Type | 10-K | ||
| Amendment Flag | false | ||
| Document Period End Date | Dec. 31, 2019 | ||
| Document Fiscal Year Focus | 2019 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Registrant Name | INNOVATE BIOPHARMACEUTICALS, INC. | ||
| Entity Central Index Key | 0001551986 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Emerging Growth Company | true | ||
| Entity Ex Transition Period | true | ||
| Entity Small Business | true | ||
| Entity Shell Company | false | ||
| Entity Interactive Data Current | Yes | ||
| Entity Public Float | $ 39.5 | ||
| Entity Common Stock, Shares Outstanding (in shares) | 41,324,976 |